Faeth Therapeutics, Inc. (FTH) has 7 SEC Form 4 insider filings on record in the last 90 days. That includes 4 insider purchases totalling $1.3M. Most recent filing: Sept. 15, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 15, 2026 filed Sept. 11, 2026 | Vousden Karen H Director | $0 | 25,000 | 0% | No | |
|
|
||||||
| July 23, 2026 filed July 21, 2026 | Craver Josiah PAO | $0 | 30,824 | 0% | No | |
|
|
||||||
| July 23, 2026 filed July 21, 2026 | Parikh Anand Kiran President and CEO | $0 | 398,018 | 0% | No | |
|
|
||||||
| July 1, 2026 filed June 29, 2026 | STEPHENSON BRIAN C Chief Financial Officer | +$326,127 | 13,634 | +41% | No | |
|
|
||||||
| June 26, 2026 filed June 24, 2026 | STEPHENSON BRIAN C Chief Financial Officer | +$401,269 | 15,641 | +90% | No | |
|
|
||||||
Showing the 5 most recent of 7 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free